Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinical Nuclear Medicine|April 2, 2021
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult GlioblastomaGurvan Dissaux, Brieg Dissaux, David Bourhis, et al.
PET Clinics|August 26, 2025
The Importance of PET Quantification for Prognosis and Treatment Response MonitoringRonan Abgral, Clément Bailly, Ronald Boellaard, et al.
Clinical Nuclear Medicine|December 13, 2018
Uptake and Tracer Kinetic of O-(2-(18)F-fluoroethyl)-L-Tyrosine in MeningiomaVictor Basse, Gurvan Dissaux, Romuald Seizeur, et al.
Clinical Nuclear Medicine|March 30, 2026
Short Dynamic 68GA-PSMA PET Reconstruction to Differentiate Urinary Excretion From Extra-urinary Uptakes With LAFOV-PETLudovic Delhom, David Bourhis, Olivier Delcroix, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
Lung Stereotactic Body Radiation Therapy in a Patient with Severe Lung Function Impairment Allowed by Gallium-68 Perfusion PET/CT Imaging: A Case ReportFrançois Lucia, Mohamed Hamya, Fanny Pinot, et al.
Archiwum Medycyny Sadowej I Kryminologii|August 25, 2021
Contribution of dual-energy computed tomography in the differentiation of illicit drugsAntoine Boizet, Julien Ognard, Ons Hmandi, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|December 8, 2023
Energy consumption in MRI: Determinants and management optionsMateusz Chodorowski, Julien Ognard, Àlex Rovira, et al.
International Journal of Legal Medicine|May 24, 2020
Feasibility of use of medical dual energy scanner for forensic detection and characterization of explosives, a phantom studyJulien Ognard, David Bourhis, Romain Cadieu, et al.
Cancers|January 8, 2023
Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade GliomaBastien Allard, Brieg Dissaux, David Bourhis, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 22, 2025
Survival impact of a KEAP1-NFE2L2 radiomics model in PDL1 ≥ 50% non-small cell lung cancer treated with pembrolizumab: the PEMBROMIC studyColine Le Meur, Karim Amrane, Renaud Descourt, et al.
Pageof 6